NCT07209761: A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
- State
- Under way
- Phase
- Phase 3
- People
- 532 planned
- Started
- 16 Oct 2025
- Primary completion
- 29 Sep 2028
- Arms
- BPaQM for fluoroquinolone-susceptible RR/MDR-TB, BPaQ for fluoroquinolone-resistant RR/MDR-TB
- Results
- None posted
- 7 Oct 2025: Trial registered
- 16 Oct 2025: Trial started